SiSaf Ltd, an RNA therapeutics company, is pleased to announce the publication in the peer-reviewed journal Molecular Therapy Nucleic Acids(1) of positive in vivo data demonstrating the safety and efficacy of its siRNA therapy for Autosomal Dominant Osteopetrosis 2 (ADO2). The data reported in the paper demonstrate .
Peer-Reviewed Publication of Positive Preclinical Data of SiSaf s SIS-ADO2 siRNA Program to Treat Rare Genetic Bone Disorder Osteopetrosis tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Kidney disease patients needed for national trial miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
UChicago Medicine was named a Center of Excellence by the Polycystic Kidney Disease (PKD) Foundation for its work caring for patients with Autosomal Dominant PKD, a life-threatening genetic disease that causes kidney failure.